Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study
Ignace Vergote, Larry J. Copeland, Toon Van Gorp, Annouschka Laenen, Giovanni Scambia, Premal H. Thaker, David Cibula, Nicoletta Colombo, Jayanthi Lea, Antonio Gonzalez-Martin, Jacob Korach, Jalid Sehouli, Bradley J. Monk, Viola Heinzelmann-Schwarz, Regina Berger, Joseph Buscema, Susie Lau, Radoslaw Mądry, Hannelore Denys, Jessica Thomes PepinVanda Salutari, Andrea Bagaméri, Antonio Ardizzoia, Stéphanie Henry, Sabrina Chiara Cecere, Martin Hruda, David A. Iglesias, Luis Manso, Ayelet Shai, David M. O'Malley
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study'. Together they form a unique fingerprint.